Zantac: Effective Relief from Heartburn and Acid Reflux
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 120 | $0.37 | $44.18 (0%) | 🛒 Add to cart |
| 180 | $0.31 | $66.27 $56.23 (15%) | 🛒 Add to cart |
| 270 | $0.27 | $99.41 $73.30 (26%) | 🛒 Add to cart |
| 360 | $0.25
Best per pill | $132.55 $89.37 (33%) | 🛒 Add to cart |
Synonyms | |||
Zantac, known generically as ranitidine, is a histamine-2 blocker that provides clinically proven, fast-acting relief from excess stomach acid. It is a well-established pharmaceutical agent trusted by healthcare professionals for decades to manage and prevent conditions related to gastric acid hypersecretion. By selectively inhibiting histamine at H₂ receptors on parietal cells, Zantac significantly reduces acid production, offering symptomatic relief and promoting healing of acid-related damage to the esophagus and stomach. Its efficacy and safety profile make it a cornerstone in the management of common gastrointestinal complaints.
Features
- Active Ingredient: Ranitidine hydrochloride
- Available Strengths: 75 mg (over-the-counter), 150 mg, and 300 mg (prescription strength)
- Formulation: Coated tablets and effervescent tablets for oral administration
- Mechanism of Action: Selective competitive inhibition of histamine H₂ receptors
- Onset of Action: Symptomatic relief typically begins within 30 to 60 minutes
- Duration of Effect: Acid suppression lasts for up to 12 hours per dose
- Bioavailability: Approximately 50% oral bioavailability, not significantly affected by food
- Metabolism: Hepatic, primarily via cytochrome P450 system
- Excretion: Renal, with a half-life of 2–3 hours
Benefits
- Provides rapid and sustained relief from heartburn, acid indigestion, and sour stomach
- Reduces the frequency and severity of gastroesophageal reflux disease (GERD) symptoms
- Promotes healing of erosive esophagitis and prevents its recurrence
- Decreases gastric acid volume and concentration, lowering risk of acid aspiration
- Helps manage conditions where acid reduction is therapeutic, such as Zollinger-Ellison syndrome
- Available in multiple strengths and formulations to suit individual patient needs and preferences
Common use
Zantac is indicated for the short-term treatment and maintenance therapy of active duodenal ulcers. It is also prescribed for the treatment of benign gastric ulcers, GERD, and erosive esophagitis. For over-the-counter use, it is approved for the prevention and relief of heartburn, acid indigestion, and sour stomach associated with these conditions. In clinical settings, it may be used prophylactically to reduce the risk of upper gastrointestinal bleeding in critically ill patients and to manage pathological hypersecretory conditions.
Dosage and direction
Dosage varies based on indication, severity, and formulation. For OTC relief of heartburn: adults and children 12 years and older may take one 75 mg tablet with water as needed, not to exceed two tablets in 24 hours. For prescription strengths: active duodenal ulcer treatment typically involves 150 mg twice daily or 300 mg once at bedtime for 4–8 weeks. Maintenance therapy is often 150 mg at bedtime. For GERD: 150 mg twice daily. Dosage must be individualized; patients with renal impairment require adjusted dosing. Tablets should be swallowed whole, with or without food. Do not crush or chew.
Precautions
Patients should inform their healthcare provider of any history of kidney or liver disease, phenylketonuria (for effervescent formulations containing aspartame), or porphyria. Long-term use may lead to vitamin B12 deficiency; monitor levels in patients on extended therapy. Use with caution in immunocompromised patients due to potential risk of bacterial overgrowth. Not recommended for use beyond 14 days for OTC symptoms without medical consultation. Discontinue use and seek medical advice if symptoms worsen or persist.
Contraindications
Zantac is contraindicated in patients with known hypersensitivity to ranitidine or any component of the formulation. It should not be used by individuals with a history of acute porphyria. Concomitant use with certain HIV protease inhibitors (e.g., atazanavir, rilpivirine) is contraindicated due to significant reductions in their plasma concentrations, which may lead to loss of therapeutic effect and development of resistance.
Possible side effect
Common side effects may include headache, constipation, diarrhea, nausea, vomiting, and abdominal discomfort. Rare but serious adverse effects can include mental confusion (particularly in elderly or renally impaired patients), hepatitis, pancreatitis, and blood dyscrasias such as thrombocytopenia. Cardiovascular effects like bradycardia and AV block are rare. Hypersensitivity reactions, including anaphylaxis, bronchospasm, and rash, have been reported. Immediately discontinue use and seek medical attention if severe reactions occur.
Drug interaction
Ranitidine may alter the absorption or metabolism of drugs that are pH-dependent (e.g., ketoconazole, itraconazole) or that require gastric acid for activation. It can increase the bioavailability of midazolam and similar drugs. Concurrent use with procainamide may increase its levels. Ranitidine is a weak inhibitor of CYP450 enzymes; monitor patients on warfarin, phenytoin, or theophylline. Avoid concomitant use with atazanavir, delavirdine, and rilpivirine.
Missed dose
If a dose is missed, take it as soon as remembered. However, if it is almost time for the next scheduled dose, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Consistency in dosing is important for maintaining acid suppression, particularly in ulcer healing and GERD management.
Overdose
Symptoms of overdose may include exaggerated pharmacological effects such as hypotension, tachycardia, and mental status changes. Management is supportive and symptomatic. Gastric lavage may be considered if ingestion was recent. Hemodialysis may remove approximately 30–40% of circulating ranitidine and can be considered in severe cases, particularly with renal impairment. There is no specific antidote.
Storage
Store at room temperature (15–30°C or 59–86°F) in a dry place, protected from light and moisture. Keep the bottle tightly closed. Do not store in the bathroom or other humid areas. Keep all medications out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Do not disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
“Prescribed Zantac 150 mg bid for my GERD. Noticeable symptom reduction within the first week. No significant side effects. Effective for nighttime acid control.” – Verified Patient
“As a gastroenterologist, I have used ranitidine for years in patients with peptic ulcer disease. It’s predictable, effective, and generally well-tolerated. The OTC formulation provides accessible relief for intermittent heartburn.” – Medical Professional
“Used OTC Zantac for occasional heartburn after meals. Works within the hour and lasts. Prefer it to antacids that need frequent dosing. Convenient and reliable.” – Consumer Review

